Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.485M
March 31, 2026 -1.476M
December 31, 2025 -1.472M
September 30, 2025 -1.461M
June 30, 2025 -1.555M
March 31, 2025 -0.804M
December 31, 2024 -0.903M
September 30, 2024 -1.012M
June 30, 2024 -1.013M
March 31, 2024 -1.872M
December 31, 2023 -1.89M
September 30, 2023 -1.906M
June 30, 2023 -1.927M
March 31, 2023 -1.95M
December 31, 2022 -1.904M
Date Value
September 30, 2022 -1.816M
June 30, 2022 -1.735M
March 31, 2022 -1.646M
December 31, 2021 -1.624M
September 30, 2021 -2.297M
June 30, 2021 -2.326M
March 31, 2021 -2.317M
December 31, 2020 -2.367M
September 30, 2020 -1.819M
June 30, 2020 -1.883M
March 31, 2020 -1.983M
December 31, 2019 -2.046M
September 30, 2019 -1.525M
June 30, 2019 -1.026M
March 31, 2019 -0.526M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Viking Therapeutics, Inc. -0.45M
Capricor Therapeutics, Inc. -2.095M
Ardelyx, Inc. 422.15M
Biomea Fusion, Inc. -0.513M
ARS Pharmaceuticals, Inc. 83.45M